A breakthrough dermal filler containing 30% calcium hydroxylapatite microspheres (CaHA) in a 70% hydrating polymer gel matrix. Clinically validated to deliver 18-24 month longevity with 94% patient satisfaction in clinical trials. FDA-cleared formula stimulates natural collagen production while restoring volume and contour.

Key Clinical Benefits:

Advanced Delivery System:

Medical-Grade Packaging:

Certified Injection Protocol:

Medical Disclaimer: Results may vary based on individual tissue response and injection technique. Must be administered by board-certified practitioners only. Contraindicated for patients with hypersensitivity to CaHA compounds. Not FDA-approved for breast augmentation or bone replacement.